PL4003532T3 - Krystaliczne postacie 7-chloro-2-(4-(3-metoksyazetydyn-1-ylo)cykloheksylo)-2,4-dimetylo-n-((6-metylo-4-(metylotio)-2-okso-1,2-dihydropirydyn-3-ylo)metylo)benzo[d][1,3]dioksolo-5-karboksyamidu - Google Patents
Krystaliczne postacie 7-chloro-2-(4-(3-metoksyazetydyn-1-ylo)cykloheksylo)-2,4-dimetylo-n-((6-metylo-4-(metylotio)-2-okso-1,2-dihydropirydyn-3-ylo)metylo)benzo[d][1,3]dioksolo-5-karboksyamiduInfo
- Publication number
- PL4003532T3 PL4003532T3 PL20754482.6T PL20754482T PL4003532T3 PL 4003532 T3 PL4003532 T3 PL 4003532T3 PL 20754482 T PL20754482 T PL 20754482T PL 4003532 T3 PL4003532 T3 PL 4003532T3
- Authority
- PL
- Poland
- Prior art keywords
- methyl
- methoxyazetidin
- dihydropyridin
- dioxole
- methylthio
- Prior art date
Links
- HUSYTLMIRXITQS-UHFFFAOYSA-N 1,3-benzodioxole-5-carboxamide Chemical compound NC(=O)C1=CC=C2OCOC2=C1 HUSYTLMIRXITQS-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/443—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962878012P | 2019-07-24 | 2019-07-24 | |
| PCT/US2020/043178 WO2021016414A1 (en) | 2019-07-24 | 2020-07-23 | Crystalline forms of 7-chloro-2-(4-(3-methoxyazetidin-1-yl)cyclohexyl)-2,4-dimethyl-n-((6-methyl-4-(methylthio)-2-oxo-1,2-dihydropyridin-3-yl)methyl)benzo[d][1,3]dioxole-5-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4003532T3 true PL4003532T3 (pl) | 2025-02-03 |
Family
ID=72047059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL20754482.6T PL4003532T3 (pl) | 2019-07-24 | 2020-07-23 | Krystaliczne postacie 7-chloro-2-(4-(3-metoksyazetydyn-1-ylo)cykloheksylo)-2,4-dimetylo-n-((6-metylo-4-(metylotio)-2-okso-1,2-dihydropirydyn-3-ylo)metylo)benzo[d][1,3]dioksolo-5-karboksyamidu |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US20220251073A1 (pt) |
| EP (2) | EP4442261A3 (pt) |
| JP (2) | JP7603653B2 (pt) |
| KR (1) | KR20220041129A (pt) |
| CN (2) | CN118852139A (pt) |
| AU (1) | AU2020316073A1 (pt) |
| BR (1) | BR112022001161A2 (pt) |
| CA (1) | CA3148447A1 (pt) |
| CL (1) | CL2022000175A1 (pt) |
| CO (1) | CO2022001482A2 (pt) |
| DK (1) | DK4003532T3 (pt) |
| ES (1) | ES2997972T3 (pt) |
| FI (1) | FI4003532T3 (pt) |
| HR (1) | HRP20241443T1 (pt) |
| HU (1) | HUE069127T2 (pt) |
| IL (1) | IL289972A (pt) |
| LT (1) | LT4003532T (pt) |
| MA (1) | MA56661B1 (pt) |
| MD (1) | MD4003532T2 (pt) |
| MX (2) | MX2022000931A (pt) |
| MY (1) | MY207951A (pt) |
| PE (1) | PE20220562A1 (pt) |
| PH (1) | PH12022550188A1 (pt) |
| PL (1) | PL4003532T3 (pt) |
| PT (1) | PT4003532T (pt) |
| RS (1) | RS66244B1 (pt) |
| SI (1) | SI4003532T1 (pt) |
| SM (1) | SMT202400485T1 (pt) |
| WO (1) | WO2021016414A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3100977A1 (en) | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| US20250059180A1 (en) * | 2022-01-14 | 2025-02-20 | Dong Wha Pharm. Co., Ltd. | 1,3-benzodioxole derivative compound and pharmaceutical composition comprising same |
| IL317228A (en) | 2022-06-13 | 2025-01-01 | Treeline Biosciences Inc | BCL6 quinolone bifunctional joints |
| CA3258412A1 (en) | 2022-06-13 | 2023-12-21 | Treeline Biosciences, Inc. | HETEROBORCTIONAL BCL6 DEGRADING AGENTS 1,8-NAPHTHYRIDIN-2-ONE |
| KR20250036219A (ko) | 2022-07-15 | 2025-03-13 | 콘스텔레이션 파마슈티칼스, 인크. | At-풍부 상호작용 도메인-함유 단백질 1a(arid1a) 돌연변이 암의 치료를 위한 ezh2 억제 요법 |
| CN115403040B (zh) * | 2022-08-11 | 2023-08-01 | 中国地质大学（北京） | 一种可通过光辐射调控导热系数的偶氮苯聚合物表面修饰的金刚石纳米粒子及其制备方法 |
| WO2024038115A1 (en) | 2022-08-17 | 2024-02-22 | Morphosys Ag | Therapy comprising anti-cd19 antibody and ezh2 modulators |
| CN119997955A (zh) | 2022-10-06 | 2025-05-13 | 星座制药公司 | 用于治疗brca1相关蛋白（bap1）突变的癌症的ezh2抑制疗法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20130186801A1 (en) * | 2012-01-25 | 2013-07-25 | Vertex Pharmaceuticals Incorporated | Formulations of 3-(6-(1-(2,2-difluorobenzo[d][1,3]dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid |
| KR102219441B1 (ko) * | 2013-02-11 | 2021-02-23 | 콘스텔레이션 파마슈티칼스, 인크. | 메틸 변형 효소 조절제, 이의 조성물 및 용도 |
| SI3121175T1 (sl) * | 2014-03-17 | 2020-07-31 | Daiichi Sankyo Company, Limited | Derivati 1,3-benzodioksola kot EZH1 in/ali EZH2 inhibitorji |
| US10577350B2 (en) * | 2015-08-28 | 2020-03-03 | Constellation Pharmaceuticals, Inc. | Crystalline forms of (R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide |
| US11311524B2 (en) * | 2017-01-19 | 2022-04-26 | Daiichi Sankyo Company, Limited | Pharmaceutical composition used for treatment of HTLV-1-associated myelopathy |
| KR102798145B1 (ko) * | 2018-04-18 | 2025-04-22 | 콘스텔레이션 파마슈티칼스, 인크. | 메틸 변형 효소 조절제, 이의 조성물 및 용도 |
| CA3100977A1 (en) * | 2018-05-21 | 2019-11-28 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
-
2020
- 2020-07-23 PL PL20754482.6T patent/PL4003532T3/pl unknown
- 2020-07-23 RS RS20241327A patent/RS66244B1/sr unknown
- 2020-07-23 HR HRP20241443TT patent/HRP20241443T1/hr unknown
- 2020-07-23 BR BR112022001161A patent/BR112022001161A2/pt unknown
- 2020-07-23 CN CN202410901775.XA patent/CN118852139A/zh active Pending
- 2020-07-23 LT LTEPPCT/US2020/043178T patent/LT4003532T/lt unknown
- 2020-07-23 MX MX2022000931A patent/MX2022000931A/es unknown
- 2020-07-23 SI SI202030528T patent/SI4003532T1/sl unknown
- 2020-07-23 HU HUE20754482A patent/HUE069127T2/hu unknown
- 2020-07-23 PE PE2022000116A patent/PE20220562A1/es unknown
- 2020-07-23 DK DK20754482.6T patent/DK4003532T3/da active
- 2020-07-23 KR KR1020227005690A patent/KR20220041129A/ko active Pending
- 2020-07-23 FI FIEP20754482.6T patent/FI4003532T3/fi active
- 2020-07-23 PT PT207544826T patent/PT4003532T/pt unknown
- 2020-07-23 ES ES20754482T patent/ES2997972T3/es active Active
- 2020-07-23 JP JP2022504532A patent/JP7603653B2/ja active Active
- 2020-07-23 US US17/628,947 patent/US20220251073A1/en active Pending
- 2020-07-23 MY MYPI2022000428A patent/MY207951A/en unknown
- 2020-07-23 WO PCT/US2020/043178 patent/WO2021016414A1/en not_active Ceased
- 2020-07-23 CA CA3148447A patent/CA3148447A1/en active Pending
- 2020-07-23 MA MA56661A patent/MA56661B1/fr unknown
- 2020-07-23 MD MDE20220601T patent/MD4003532T2/ro unknown
- 2020-07-23 AU AU2020316073A patent/AU2020316073A1/en active Pending
- 2020-07-23 EP EP24182094.3A patent/EP4442261A3/en active Pending
- 2020-07-23 SM SM20240485T patent/SMT202400485T1/it unknown
- 2020-07-23 PH PH1/2022/550188A patent/PH12022550188A1/en unknown
- 2020-07-23 EP EP20754482.6A patent/EP4003532B1/en active Active
- 2020-07-23 CN CN202080066219.5A patent/CN114450279B/zh active Active
-
2022
- 2022-01-19 IL IL289972A patent/IL289972A/en unknown
- 2022-01-21 MX MX2025004573A patent/MX2025004573A/es unknown
- 2022-01-24 CL CL2022000175A patent/CL2022000175A1/es unknown
- 2022-02-15 CO CONC2022/0001482A patent/CO2022001482A2/es unknown
-
2024
- 2024-12-09 JP JP2024214565A patent/JP7692524B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL289972A (en) | Crystalline forms of 7-chloro-2-(4-(3-methoxyazatidin-1-yl)cyclohexyl)-4,2-dimethyl-n-((6-methyl-4-(methylthio)-2-oxo-2, 1-dihydropyridin-3-yl)methyl)benzo[d][3,1]dioxole-5-carboxamide | |
| IL288104A (en) | Heterocyclic compounds, preparation methods and their use | |
| ZA202205758B (en) | Substituted heterocyclic fused cyclic compound, preparation method therefor and pharmaceutical use thereof | |
| ZA201605424B (en) | Crystalline solid forms of n-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-n'-(4-fluorophenyl) cyclopropane-1, 1-dicarboxamide, processes for making, and methods of use | |
| HUE060152T2 (hu) | 4-(3H-indol-5-il)-N-(piridin-2-il)pirimidin-2-amin-származékok mint proteinkináz inhibitorok, elõállítási eljárásuk és gyógyászati alkalmazásuk | |
| EP4043462A4 (en) | COMPOUND WITH BRD4-INHIBITING EFFECT, PRODUCTION METHOD THEREOF AND USE THEREOF | |
| EP3527183B8 (en) | Absorbent core, articles comprising said core, and methods of making | |
| GB202101909D0 (en) | Novel crystalline form of pyroxa-sulfone, methods for its preparation and use of the same | |
| EP3929185A4 (en) | CONDENSED CYCLIC COMPOUND CONTAINING NITROGEN, METHOD FOR PREPARATION AND USE | |
| EP4295910A3 (en) | Methods for treating multiple sclerosis using pyrimidine and pyridine compounds with btk inhibitory activity | |
| GB202017416D0 (en) | Sensor elements and assemblies, cutting tools comprising same and methods of using same | |
| EP3551215A4 (en) | METHOD FOR THE PRODUCTION AND EXTENDED STORAGE OF GROWTH FACTORS AND CYTOKINES FROM PLASTIC-PLASTIC THROMBYCYTES | |
| GB202204889D0 (en) | Pyridine sulfonamide phosphate compound, preparation method therefor and application thereof | |
| EP3530650A4 (en) | CRYSTALLINE FORM OF (R) -4-HYDROXY-2-OXO-1-PYRROLIDINE ACETAMIDE, PRODUCTION METHOD THEREFOR, AND USE THEREOF | |
| IL291721A (en) | 5-bromo-2'6-d1(1h-pyrsol-1-yl)pyrimidine-4-amine and new salts | |
| IL263356A (en) | A crystalline form of a compound that suppresses protein kinase activity, and its application | |
| EP4075890A4 (en) | IAB MULTIPLEXING METHOD AND TEMPORAL RELATIONSHIP, AND NODE USING SAME | |
| DK4036095T3 (da) | 4-fluor-1h-pyrazolo[3,4-c]pyridinderivater som selektive bruton-tyrosinkinase- (btk) inhibitorer til behandlingen af b-cellelymfom og autoimmunsygdomme | |
| IL274963A (en) | Thiano[2,3-d]pyrimidine compound with inhibitory activity for protein kinase | |
| SG11202111907UA (en) | Solid form of diaminopyrimidine compound or hydrate thereof, preparation method therefor, and application thereof | |
| EP4054571A4 (en) | FENTANYL HAPTEN, FENTANYL HAPTEN CONJUGATES, AND METHODS OF MAKING AND USING THE SAME | |
| EP4069689A4 (en) | SUBSTITUTED IMIDAZOLECARBOXAMIDE AS BRUTON TYROSINKINASE INHIBITORS | |
| SG11202111558VA (en) | Crystalline form of compound, method for preparing the same, pharmaceutical composition and use | |
| EP3810551A4 (en) | CRYSTALLINE METAL PHOSPHATE, THEIR PROCESS OF PRODUCTION AND USE | |
| HK40113576A (zh) | 用於制备1，3-苯并二氧杂环戊烯杂环化合物的方法 |